Original Articles
Fair pricing of "old" orphan drugs: considerations for Canada's orphan drug policy
Eve A. Roberts, Matthew Herder and Aidan Hollis
CMAJ February 23, 2015 cmaj.140308; DOI: https://doi.org/10.1503/cmaj.140308
Eve A. Roberts
Division of Gastroenterology, Hepatology and Nutrition (Roberts), The Hospital for Sick Children; Departments of Paediatrics, Medicine, and Pharmacology and Toxicology (Roberts), University of Toronto, Toronto, Ont.; Health Law Institute (Herder), Faculties of Medicine and Law, Dalhousie University, Halifax, NS; Department of Economics (Hollis), University of Calgary, Alta.
Matthew Herder
Division of Gastroenterology, Hepatology and Nutrition (Roberts), The Hospital for Sick Children; Departments of Paediatrics, Medicine, and Pharmacology and Toxicology (Roberts), University of Toronto, Toronto, Ont.; Health Law Institute (Herder), Faculties of Medicine and Law, Dalhousie University, Halifax, NS; Department of Economics (Hollis), University of Calgary, Alta.
Aidan Hollis
Division of Gastroenterology, Hepatology and Nutrition (Roberts), The Hospital for Sick Children; Departments of Paediatrics, Medicine, and Pharmacology and Toxicology (Roberts), University of Toronto, Toronto, Ont.; Health Law Institute (Herder), Faculties of Medicine and Law, Dalhousie University, Halifax, NS; Department of Economics (Hollis), University of Calgary, Alta.
This is a PDF-only article.
In this issue
Article tools
Fair pricing of "old" orphan drugs: considerations for Canada's orphan drug policy
Eve A. Roberts, Matthew Herder, Aidan Hollis
CMAJ Feb 2015, cmaj.140308; DOI: 10.1503/cmaj.140308
Jump to section
Related Articles
Cited By...
- No citing articles found.